DeSmogBlog, a climate activist website that ruthlessly smears scientists, is headed by Brendan DeMelle, an anti-vaxxer who helped RFK, Jr. write an infamous and since-retracted article linking vaccines to autism.

"You never let a serious crisis go to waste. And what I mean by that it's an opportunity to do things you think you could not do before." -- Rahm Emmanuel [1]

The website’s strategy is clear: Throw ad hominem attacks as early and as often as possible. Why? Because it works. And the people most eager to spread the lies are self-proclaimed skeptical scientists and journalists.

Chloroquine, the old malaria drug, is making news as a potential therapy for coronavirus. Does it belong in the headlines for its antiviral properties, or is it just hype and bluster? Will it become a drug? Let's find out.

One way in which COVID-19 is not novel is that the disease follows a set pattern: first onset, then the body’s response, followed (hopefully) by recovery. To get a better sense of how this pandemic might play out, we should consider what we know about COVID-19’s timeline. 

At the current time, influenza remains the far bigger threat to global public health than COVID-19. Though COVID-19 has a higher case-fatality rate, influenza infects far more people. Of course, that could change.

Dr. David Shlaes' primary expertise is in bacterial infections and antibiotics. So it's not surprising that our ACSH advisor is wondering about secondary bacterial infections from coronavirus infections. Will there be antibiotics to combat the infections this time? How about next time?

Here's what's on tap: The how-to of COVID-19 testing ... an extremely well-informed skeptic wonders about our pandemic actions ... a possible silver lining to the massive economic fallout ... and what's behind the long lines of climbers trying to summit Mount Everest?

As the horror known as the coronavirus tightens its grip on the world, and a vaccine is years away, our best hope is an antiviral drug that minimizes the damage caused by coronavirus replication. New data on favipiravir, a repurposed drug originally discovered in Japan, looks promising in trials in China. But nothing is ever straightforward in drug discovery -- and that is no different here. Here's a summary of the new findings.

Testing performs both diagnostic and treatment roles, and testing for COVID-19 is no exception. Unlike other forms of testing, knowing your COVID-19 status will not alter your disease course or modify specific therapy. But it will determine where you spend the next few weeks, either at home or the hospital.